Neurological diseases cause severe damage due to neuroinflammation mediated by immune cells. Managing this inflammation poses a challenge because the brain is protected by the skull and additional ...
LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal ...
Cells hidden in the skull may point to a way to detect, diagnose and treat inflamed brains. A detailed look at the skull reveals that bone marrow cells there change and are recruited to the brain ...
US-based bone adhesive company RevBio has received the Food and Drug Administration’s (FDA) investigational device exemption (IDE) approval to conduct a clinical trial of its cranial flap bone glue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results